ACTU vs AMGN: Which Stock is Better?
Side-by-side comparison of Actuate Therapeutics Inc and Amgen Inc in 2026
ACTU
Actuate Therapeutics Inc
$5.56
AMGN
Amgen Inc
$331.00
Key Metrics Comparison
| Metric | ACTU | AMGN | Winner |
|---|---|---|---|
| Market Cap | $136.67M | $178.24B | AMGN |
| P/E Ratio | N/A | 25.58 | AMGN |
| EPS (TTM) | $N/A | $12.94 | AMGN |
| Revenue Growth | 0.0% | 0.1% | AMGN |
| Gross Margin | 0.0% | 70.1% | AMGN |
Analyze ACTU
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACTU or AMGN a better investment?
Comparing ACTU and AMGN: Actuate Therapeutics Inc has a market cap of $136.67M while Amgen Inc has $178.24B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACTU and AMGN?
ACTU (Actuate Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACTU or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACTU or AMGN?
AMGN has higher revenue growth at 0.1% vs 0.0% for ACTU.
Which company is more profitable: ACTU or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.1% compared to 0.0% for ACTU.
Which is the larger company: ACTU or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $178.24B compared to $136.67M for ACTU.
Should I buy ACTU or AMGN in 2026?
Both ACTU and AMGN have investment merit. ACTU trades at $5.56 while AMGN trades at $331.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACTU and AMGN stock?
Key differences: Market Cap ($136.67M vs $178.24B), P/E Ratio (N/A vs 25.6x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 70.1%).